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2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) has suddenly become the focal point of controversy over
the relationship of chemical waste to human health. Specific concern exists regarding its potential as-
sociationwithhumanmalignancy. Subcellular, cellular, andwhole-animal experiments suggestthatTCDD
exerts much of its activity by inducing enzymes that protect the intact organism from the assault of
environmental contamination. TCDD is a potent inducer ofaryl hydrocarbon hydroxylase, although wide
variations between species do exist. Conventional tests for mutagenicity have produced conflicting results.
Animal experiments have shown thedevelopment oftumors following chronic low level ingestion ofTCDD.
The human evidence regarding the potential carcinogencity of TCDD comes from occupational, military
and environmental exposures. Several studies have come out ofSweden suggesting an association between
sarcoma and exposure to herbicides. Although there is little solid evidence that 2,3,7,8-TCDD produces
substantial chronic disability or premature death in man, a significant body of experimental evidence for
its carcinogenicity makes it likely that a small number of human malignancies may be due to its action.
Since2,3,7,8-TCDD is an unwantedcontaminant it could beeliminated with little measurable consequence.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD or
"dioxin"), an unwanted by-product resulting from the
manufacture of the herbicide 2,4,5-trichlorphenoxy-
aceticacid(2,4,5-T) andthegermicidehexachlorophene,
has suddenly become the focal point ofcontroversy over
therelationship ofchemicalwaste tohumanhealth. This
isomer, one of22 isomers ofTCDD, was first identified
by the German chemist Sorge in 1956, in an investi-
gationintothe cause ofindustrial chloracne (1). Reports
published between 1949 and 1973 described a human
syndrome that included chloracne, liver disease, pe-
ripheral neuropathy, porphyria cutanea tarda and psy-
chological abnormalities but the possibility ofmalignancy
was not considered. The use of Herbicide Orange in
Vietnam, the accidental use of TCDD-contaminated
waste oil for dust control in Missouri, and the spill of
wood preservative containing about 30 ppb ofTCDD in
Sturgeon, Missouri, in 1979 have provoked a flurry of
scientific, political, and legal activity. Forty-seven rail-
road employees who participated in the Sturgeon cleanup
were awarded $58 million dollars in 1982 (the decision
was later overturned in appellate action), and 15,000
veterans were awarded 180 million dollars in an out-of-
court settlement in 1984. These large settlements mainly
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reflect concern for the present or future development
ofmalignant disease and fetal transmission ofgerm cell
mutations that might produce birth defects. This paper
reviews the theoretical, experimental, and epidemio-
logic evidence for the carcinogenic potential of TCDD.
A number of animal studies performed over the past
decade have shown that TCDD is not only the most
toxic ofthe 22 isomers ofTCDD but, based on an LD,,
of 2 ,ug/kg in guinea pigs, is believed to be one of the
mosttoxic substances eversynthesized (2). The toxicity
of2,3,7,8-TCDD, based on lethal doses for guinea pigs,
is 2000 times greater than that of 1,3,6,8-TCDD and at
least 20,000 times greater than that of other tetrach-
lorinatedphenols. Inthispaper, theabbreviationTCDD
refers to the 2,3,7,8 isomer; the same convention is usu-
ally followed in the literature.
Substantial species differences do exist. Guinea pigs
and chickens appear most sensitive, rabbits and mice
are least sensitive, while monkeys and rats have an
intermediate sensitivity (3). Humans are probably on
the less sensitive end of the spectrum.
TCDD is an extremely stable solid that is insoluble
inwater, slightlysoluble infat, andnonvolatile although
airborne spread by adsorption to particulate material
occurs. It is absorbed from the gastrointestinal tract,
lungs, and skin and is distributed to the organs in re-
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species have ranged from 12 to 50 days, but clearance
is almost certainly nonlinear, so that small concentra-
tions may persist for prolonged periods of time.
Exposure ofprimates to TCDD produces progressive
weight loss, alopecia, and edema (4). Chloracne, a hall-
mark of human exposure, and blepharitis due to im-
paction of Meibomian glands are due to metaplastic
changes in sebaceous glands that lead to secretion of a
viscous material which plugs and destroys glandular
material. Loss of body fat, involution of the thymus
gland, ascites, testicular degeneration restricted to the
seminiferous components, bone marrow hypocellular-
ity, and reduction in plasma albumin are all seen in the
exposed primate. Hepatic lesions including necrosis and
fatty infiltration are found in mice, rats, rabbits, and
chickens but are minimal in primates. Liver porphyrins
are markedly increased in mice and chickens exposed
to low concentrations of TCDD, porphyrins are only
minimallyincreased followingexposureinprimates. Fe-
totoxicity and decreased fertility has also beenreported
in mice and rats (5).
Cellular and Subcellular Actions of
2,3,7,8-TCDD
TCDD induces a number of enzymes, including aryl
hyroxylase, glucuronyltransferase and 5-aminolevulinic
acid (ALA) synthetase (6). The induction of ALA syn-
thetase leads to anincreased concentration ofporphyrin
precursors in liver and urine. An additional action in-
hibitingthe activity ofuroporphyrinogen decarboxylase
leads to a significant increase in the uroporphyrin/co-
proporphyrin ratio. Hepatomegaly and a dose-related
proliferation of the rough endoplasmic reticulum are
morphologic correlates of these biochemical observa-
tions since the microsomal monooxygenase system is
embedded in that structure.
The ability of chlorinated dibenzo-p-dioxins and pol-
ychlorinated biphenyls (PCBs) to induce the hepatic
monooxygenase system hints at a potential role in car-
cinogenesis since that system is responsible for the ox-
idation offoreign chemicals and steroids (7). Two types
ofmonooxygenase inducers have been identified. Phen-
obarbital, for example, induces the terminal oxidase cy-
tochrome P-450 and increases the metabolism of a
number of substrates, while 3-methylcholanthrene in-
duces a closely related terminal oxidase, cytochrome P-
448. The prototype of this monooxygenase inducer, 3-
methylcholanthrene, has been widely used experimen-
tally asacancer-promoting agent. TCDDis30,000times
more potent in inducing aryl hydrocarbon hydroxylase
(AHH) than is 3-methylcholanthrene. Poland and Glover
have shown that 2,3,7,8-TCDD binds to a specific cy-
tosolic receptor which induces AHH (8). AHH induci-
bility is inherited by a simple autosomal trait in inbred
mice and appears to be controlled by a single gene. This
may explain the wide variations in sensitivity to TCDD
exhibited by different species. Poland and Glover also
demonstrated that covalent DNA binding by TCDD is
much lower than that of most chemical carcinogens,
raisingthe possibility that carcinogenicity is not related
to somatic mutation (9).
Experimental Evidence for
Carcinogenicity in Animals
Conventional tests for mutagenicity have provided
conflicting results (3). TCDD is mutagenic in Salmo-
nella typhimurium strain TA 1532 but not in strains
TA 1535, TA 1537 and TA 1538. Mutagenicity has been
demonstrated in Escherichia coli strain Sd-4. Similar
confficting findings were reported in two-stage tumo-
rigenesis models.
Berry et al. (10) noted that TCDD inhibited tumor
initiation by 3-methylcholanthrene, while Kouri (11)
showed an enhancing effect on the formation of3-meth-
ylcholanthrene-induced sarcomas at the site of subcu-
taneous injection. Poland et al. (12) and Pitot (13) have
alsoreportedthatTCDDisapromoterofcarcinogenesis
in mice skin (Poland) and rat liver (Pitot).
A group of experimental studies has shown the de-
velopment of tumors following chronic low level inges-
tion ofTCDD. Van Miller et al. (14) administered 0.001
,ugTCDD/kg body weight/week to male rats for 78 weeks
and found a variety of tumors at 95 weeks (ear duct
carcinoma, lymphocytic leukemia, kidney adenocarci-
noma, malignant peritoneal histiocytoma, skin angios-
arcoma and carcinomas ofhard palate, tongue and nasal
turbinates). The number of animals exposed was small
and it was difficult to determine whether the incidence
ofthese tumors was greaterthan those appearing spon-
taneously. Studies conducted by the National Toxicol-
ogy Program demonstrated hepatic and thyroid tumors
in male and female rats (15,16). Male mice developed
liver cancer, female mice developed liver cancer and
thyroid follicular cell adenomas. The application ofTCDD
tothe skinoffemalemiceproduced anincreasednumber
of fibrosarcomas compared to untreated controls.
Kociba et al. administered daily oral doses to groups
of rats over a two year period (17). Ingestion of feed
containing 2.2 ppb TCDD (0.1 ,ug/kg body weight per
day) causedanincreased incidence ofhepatocellular car-
cinomas and squamous cell carcinoma ofthe lung, hard
palate/nasalturbinates, ortongue. There was areduced
incidence oftumors ofthe pituitary, uterus, mammary
glands, pancreas and adrenal glands. This dose led to
liver and fat concentrations of 24 and 8.1 ppb, and to
increased mortality, decreased weight gain, prolifera-
tion ofthe rough endoplasmic reticulum ofthe liver and
increased urinary excretion of porphyrins.
Rats fed a diet containing 0.2 ppb (0.01 ,ug/kg/day)
accumulated TCDD concentrations of 5.1 and 1.7 ppb
in liver and fat and had substantially less evidence of
toxicity. The only tumors observed were benignhepatic
nodules. Diets containing 0.022 ppb produced liver and
fat concentrations of 0.54 ppb in liver and fat. Histo-
logical, biochemical or clinical abnormalities were not
observed at this dose.
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Human Evidence for
Carcinogenicity
Occupational Exposures
Analysis of groups of workers accidentally exposed
during the manufacture of2,4,5-trichlorophenoxyacetic
acid (2,4,5-T) provides a relatively complete view ofthe
human syndrome and permits some insight into dose-
response relationships. 2,4,5-T produced prior to 1965
contained more than 30,000 ppb of2,3,7,8-TCDD. Con-
trol measures introduced sometime thereafter reduced
maximum concentrations to below 1000 ppb and, ulti-
mately, to below 100 ppb. These reports of accidental
exposure are of importance in estimating the carcino-
genic potential since exposure can be estimated both by
the known concentration ofcontaminant in the finished
product and by the severity of symptoms experienced
by the exposed population.
The first reported cases ofillness following explosive
releaseoftoxicmaterialduring themanufacture of 2,4,5-T
occurred in Nitro, WV, in 1949. An acute syndrome
characterized by skin, eye, and respiratory tract irri-
tation, headache, dizziness, and nausea subsided in sev-
eral weeks and was followed by chloracne, severe
muscular aches, and pains, fatigue, nervousness and
irritability, dyspnea, decreased libido, and intolerance
to cold. Examination revealed liver enlargement, pe-
ripheral neuropathy, prolonged prothrombin time, and
increased serum lipids.
Inall, there were 122individualswithchloracne. Most
of these abnormalities had subsided by 1953 but chlor-
acne persisted. In addition, 26 individuals with chlor-
acne associated with exposure to the routine 2,4,5-T
operation were observed between 1949 and 1953.
Three major clinical reports evaluating the health of
individuals exposed during that period have appeared.
Zack and Suskind (18) followed 122 individuals with
chloracne attributable to the 1949 accident through 1978.
There were 32 deaths observed, with 46.41 expected
from age, race, and time-specific mortality rates for the
U.S. population. There were nine deaths from malig-
nant disease, with 9.04 expected (lung, 5; acute mye-
logenous leukemia, lymphatic leukemia, Hodgkin's
disease, and malignant fibrous histiocytoma of soft tis-
sue origin).
Zack and Gaffey, in an attempt to study the chronic
effect ofTCDD in the same factory, evaluated the vital
status of 884 men who had been employed in the West
Virginia plant (19). Those exposed to 2,4,5-T were iden-
tified from employment records. Of 163 deaths ob-
served, 35 were from malignant disease. Standardized
mortality ratios (SMRs) calculated by comparison with
age, race, andtime-specific ratesforthe U.S. population
were 1.03 and 1.13, respectively; neither was statisti-
cally significant. The SMR for bladder cancer was 9.49
dueto the known carcinogenicity ofparaaminobiphenyl.
Nine of fifty-eight deaths in the exposed group were
from malignant diseases; one of these had previously
been reported by Zack and Suskind. The eight malig-
nancies included lung (6), bladder (2), and generalized
liposarcoma later diagnosed by pathologists from the
Armed Forces Institutes of Pathology as an undiffer-
entiated carcinoma. The proportional mortality rate
(PMR) for malignant disease was 0.82 in the exposed
group, 1.22 in the unexposed group. There is inevitable
overlap between the two mortality studies because dif-
ferent criteria for exposure were utilized; chloracne fol-
lowing the accident was considered evidence of acute
exposure in the first study, employment in a 2,4,5-T
manufacture department in the second. Attempts to
change group composition by avoiding overlap did not
change the overall results.
A morbidity study was undertaken in 1979, 30 years
afterthe accidental release oflarge quantities of2,3,7,8-
TCDD. Between 1948 and 1969, 204 individuals who
had workedinthe plantand 163controlindividualswere
examined by Suskind and Hertzberg (20). Chloracne
was present in 52.7% of the exposed group compared
to none of the control group. A history of peptic ulcer
and reduced lung function was more common in the
exposed group although there was no evidence of in-
creased prevalence of hepatic disease, renal abnormal-
ities or either central or peripheral nervous system
disease.
In 1953, 74 employees were exposed to TCDD-con-
taminated material after an explosion in a reaction ves-
sel in a BASF plant in Ludwigshafen, Germany (21).
Overall mortality did not differ from that in three ex-
ternal controlgroups (totalpopulationofLudwigshafen,
district of Rhinehessia-Palatinate, and entire Federal
Republic of Germany) or from two matched groups se-
lected fromunexposedfactoryworkers; however, seven
of the deaths were from malignant disease (4.1 ex-
pected) and three of these were cancer of the stomach
(0.61 expected).
Some 30 cases ofchloracne were identified by Schultz
in a chemical plant in Hamburg, Germany, during 1956
(1). Schulz and Sorge soon discovered that technical
grade 2,4,5-T, but not the pure chemical, produced an
acnelike lesion in the rabbit ear, and by 1957 it became
clear that 2,3,7,8-TCDD was the toxic substance asso-
ciated with the manufacture of 2,4,5-T.
In 1963, 145 workers were exposed to TCDD that
escaped following a factory explosion in a factory in
Amsterdam (22). Twenty years later, the status of 141
ofthese individuals was evaluated; chloracne was pres-
ent in 69. Twenty-five had died, eight with malignant
disease. Thirteen of those who died and three of those
who died from cancer had chloracne. The eight tumors
were mesothelioma (asbestos exposure), melanosar-
coma, stomach, pancreas, rectosigmoid, lung, bladder/
kidney, and brain. Standard mortality rates for all deaths
and for deaths from malignant disease were 1.19 (0.78-
1.70) and 1.15 (0.49-2.09), respectively. The nature of
the comparison population was not stated.
An explosion in the Coalite 2,4,5-TCP factory in Der-
byshire, England, in 1968, released toxic materials es-
timated to contain 30,000 to 40,000 ppb of TCDD (23).
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Chloracne developed in 70 workers and 11 workers de-
veloped abnormal liverfunction studies and white blood
cell counts. Both tests were normal in 10 days. Ten
years later, May reported that chloracne was still pres-
ent in 22 ofthe men but that other abnormalities were
not present (24). Reproductive histories and biochem-
ical studies were normal and none ofthe individuals had
developed malignant disease.
ChronicoccupationalexposuretoTCDDhasalsobeen
studied. Bleiberg etal. reported in 1946that21 workers
at a 2,4,5-T plant in Newark, NJ, developed chloracne
and that 11 ofthese had increased urinary excretion of
uroporphyrins consistent with the diagnosis of por-
phyhria cutanea tarda (25). By 1968, chemical process
changes had reduced the concentration of TCDD from
10,000 to 25,000 ppb to less than 1000 ppb. Poland et
al. later studied 73 workers and found them to be in
good health, although 13 still had chloracne (26).
Pazderova et al. presented a 10-year follow-up of 55
workers who had been chronically exposed to TCDD
during the manufacture of 2,4,5-T between 1965 and
1968 (27). Chloracne, porphyria cutanea tarda, liver in-
volvement, fatigue, and weakness ofthe lower extrem-
ities were the most common findings. Two ofsix reported
deaths during the 10-year period of observation were
from malignant disease; both of these were broncho-
genic carcinoma. Two of the deaths were from traffic
accidents.
An outbreak of chloracne occurred during 1964 at a
2,4,5-T plant in Midland, MI. Fourteen years later, Cook
et al. conducted avital status study ofthe 61 individuals
known to have worked inthe TCP process building dur-
ing that period (28). Three had died from malignant
disease (1.6 deaths expected based on age-specific rates
for U.S. white male population). One individual with
recurrent acne described as "not typical of chloracne"
died 8 years after exposure from metastatic adenocar-
cinoma of unknown primary site, another with a rash
oftheright earand face butwithout definitive diagnosis
of chloracne died 11 years later of a fibrosarcoma, and
another with chloracne died 12 years after exposure
from aglioma. Ott etal., inan analysis ofanothercohort
from Midland, MI, observed four deaths in 204 employ-
ees working in the department responsible forthe man-
ufacture of2,4,5-T (29). One death was from carcinoma
ofthe lung which was not statistically significant when
compared to the age-specific mortality for U.S. white
males.
Military and Nonoccupational Exposures
to 2,3,7,8-TCDD
Approximately 19 million gallons of herbicide con-
taining 2,4,5-T were sprayed over Vietnam between
1962and 1971 (30). ThetwomissionsofOperation Ranch
Hand were defoliation and crop destruction. Herbicides
Pink, Green and Purple contained up to 66,000 ppb of
TCDD and were used prior to July 1, 1965. After that
time, aerial spraying was limited to Herbicide Orange
Table 1.
No. of
malignancies
Types of malignancies in reported cohorts
Lung
Stomach
Kidney
Soft-tissue sarcoma
Leukemia
Colon
Prostate
Glioma
Testicle
Melanoma
Hodgkins
Pancreas
Tongue
Adenocarcinoma site unknown
Poorly differentiated carcinoma
Ranch hand skin malignancies (controls)
Basal cell
Melanoma
Squamous cell
22
4
3
2
2
2
2
2
2
2
1
1
1
1
1
31 (21)
3 (02)
1 (03)
which contained 2,000 ppb. The airborne crews engaged
in Operation Ranch Hand were selected for epidemio-
logic study because their almost daily occupational ex-
posure gave them "1000 times more exposure to
Herbicide Orange than would an average unclothed man,
standing in an open field directly beneath a spraying
aircraft." Mortality studies were done on 1247 exposed
Ranch Handers and 16,174 unexposed controls who
served in Vietnam. Matched controls for a morbidity
analysis were selected from this larger group of unex-
posed servicemen. Overall mortality rates for the two
groups were almost identical (Table 1).
There were fourdeaths from malignant disease inthe
Ranch Hand group (lung, unspecified, kidney, and me-
diastinal melanoma) compared to 39 in the 12,193
matched controls (odds ratio, 1.0). The morbidity study
identified 13 malignancies each in the exposed and con-
trolgroups. Malignancies in the exposed groupincluded
lung (2), kidney, lip (3), bladder (2), prostate, germ cell
neoplasm of testicle (2), and glioma. Thirty-five skin
cancers were found in the exposed group and 27 in the
comparison group. One matched control had fibrosar-
coma of the skin. Neither chloracne nor porphyria cu-
taneatardawerepresentinthe Ranch Handpopulation.
Minor birth defects, abnormal, peripheral pulses and
decreased unstimulated lymphocyte proliferation were
more common in the exposed group but other differ-
ences were not identified.
Much higher concentrations ofTCDD than were con-
tained inAgentOrange were contained inwaste oilused
for dust control in Missouri in 1971. Part of the waste
oil was obtained from a company in southwestern Mis-
souri that manufactured 2,4,5-TCP as an intermediate
fortheproductionofhexachlorophene. Shortlyafterthe
application ofwasteoilto ahorse arenainMoscowMills,
43 horses in that arena died and exhibited intestinal
colic, oral ulcers, severe weight loss, and other abnor-
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malities (31). There were 26 known abortions and many
foals exposed in utero died. A six-year-old girl who had
played in the area presented several months later with
nosebleeds, headache, diarrhea, painful urination, and
hematuria. Her symptoms disappeared within several
weeks, and a subsequent examination of the girl, her
sister, and her mother, performed by Beale et al. five
years later was completely normal (32). Kimbrough et
al. reported that the initial soil sample from the area
where the girl was playing contained about 30,000 ppb
of TCDD.
A pilot health effects study was performed in Times
Beach and other areas in Missouri where the TCDD
containing waste oil had been applied by the same in-
dividual who sprayed the horse arenas (33). A group of
68 individuals considered to have a high probability of
exposuretoTCDD were compared to36individuals who
had no exposure. There was an apparent trend of in-
creasedurinary abnormalities (more self-reported prob-
lems, leukocyturia, and hematuria) and lower helper/
suppressor-cytotoxic lymphocyte ratios in the exposed
group. No cases of chloracne, porphyria cutanea tarda
of soft tissue sarcomas were found.
A much publicized and well-studied industrial acci-
dent in a TCP factory in Seveso, Italy, has produced
chloracne, although there were surprisingly few per-
manent health consequences (34). There has been no
increase in morbidity or mortality from malignant dis-
ease, although the 8-year period of observation is too
short to permit any conclusions to be drawn about ma-
lignant disease. Presumably, plugging of an exhaust
pipe resulted in an exothermic reaction that created
extremely high concentrations of TCDD that were re-
leased in acloud overthe area. Although concentrations
as high as 15,000 ppb were found in grass samples,
vegetation was rapidly cleared and soil samples were
much less contaminated. Peoplewere exposed to ashigh
as 90 to 5000 ppb duringthe first 2 weeks but were then
evacuated.
Soft Tissue Sarcoma without Chloracne:
The Swedish Experience
The 1977 clinical observations published by Hardell
suggesting that soft tissue sarcomas appeared to be
associated with exposure to phenoxyacetic acids added
a new dimension to the question of herbicide carcino-
genicity (35). A subsequent case-control study pub-
lished by Hardell and Sandstrom in 1979 demonstrated
that individuals with sarcomas had a sixfold greater
history of exposure to phenoxyacetic acids or chloro-
phenols compared to matched controls (36).
A second study by Eriksson et al. reported similar
increased risk for soft tissue sarcoma in another group
ofindividuals from southern Sweden (37). A similar study
design led Hardell to conclude that both Hodgkins Dis-
ease and non-Hodgkins lymphoma, but not carcinoma
of the colon, were associated with phenoxyacetic acid
and chlorophenol exposure (38).
Soft tissue sarcomas were not identified. However,
in a study ofSwedish railroad workers exposed to phen-
oxy acids and amitrol (3-amino-1,2,4 triazol) during the
same time period (39), 45 deaths were observed in a
cohort of 348 railroad workers (49 deaths expected).
There were 17 tumors (11.85 expected from entire
Swedishpopulation). Thedistributionoftumortypewas
not unusual.
The two Swedish case-control studies demonstrating
a sixfold increase in herbicide exposure among patients
with soft tissue sarcoma have been widely interpreted
as strongevidenceforthe carcinogenicity ofTCDD. The
case-control approachisidealforthestudyofuncommon
events but difficulties in selecting control subjects can
produce major errors. Exposure history in the study
was retrospectively determined by questionnaire at a
time when herbicide exposure was receiving consider-
able media attention leading those with soft tissue sar-
comato overestimate herbicide contact. Concern among
herbicide workers may have led to increased medical
surveillance leading to a detection bias similar to that
demonstrated by Horwitz and Feinstein foruterine car-
cinoma and estrogen usage (40). Mortality rates for soft
tissue sarcoma were 60% in the initial study and 35%
in the second study, suggesting early diagnosis ofsmaller
lesions. In addition, documented evidence of exposure
to TCDD is uncertain and dose-response relationships
could not be identified. It is difficult to ascertain the
relative risk of exposure to TCDD because of potential
concurrent exposure to other toxic substances. In ad-
dition, chloracne or other health problems were not
mentioned and the study in southern Sweden demon-
strated that phenoxyacetic acids uncontaminated by
dioxins or dibenzofurans were also risk factors for the
development of soft tissue sarcoma.
Smith et al. conducted a similar case-control study
with 98 cases reported to the New Zealand Cancer Re-
gistry between 1976 and 1980 (41): 21 of the cases and
19 of the controls had a definite exposure history to
phenoxyacetic acids. None of the cases were found in
the more than 2000 herbicide sprayers in New Zealand,
even though a great deal of phenoxyacetic acid herbi-
cides have been utilized. Two separate studies from
Finland in workers in five companies who sprayed 2,4-D
and 2,4,5-T failed to reveal any increase in deaths from
malignant disease although headache, fatigue and a few
instances of skin involvement were reported (42). An-
other negative study was recently reported by Milham
(43), who reported that marine engineers, bankers,
laundry workers, plumbers, teachers, and students had
much higher mortality ratios for soft tissue sarcomas
than workers exposed to herbicides; the mortality ratio
forbankers is almost fourtimes thatforherbicide work-
ers, for example.
Pooling Mortality Data from Reported
Cohort Observations
It is tempting to force an answer to the carcinogen-
icity question by attempting a global integration of re-
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ported studies. Honchar and Halperin (44) reviewed
fourstudies ofworkersfromtwoUnited States chemical
companies and notes that 3 ofthe total 105 deaths were
due to soft tissue sarcoma (2.9% ofmortality compared
to an expected 0.07% for U.S. males between the ages
of 20 and 80). Three other cases were briefly reported
inthe medical literature and contributed tothe growing
belief that a relationship between soft tissue sarcoma
and exposure to TCDD exists. Fingerhut et al. have re-
evaluated the seven cases in an unpublished manuscript
that included anindependent review oftissue diagnoses
by pathologists from the Armed Forces Institute ofPa-
thology. Two of the seven pooled cases were found to
have carcinoma rather than soft tissue sarcoma, and
three others did not appear to have an adequate record
ofexposure to TCDD. Thus five ofthe seven cases were
either not soft tissue sarcomas or did not have good
evidence of exposure.
Atotalof258deathsin 1977individualsoccupationally
exposed to concentrations ofTCDD that probably ranged
from 1000 to 30,000 ppb have been reported in the lit-
erature. Since the time of observation was between 10
and 20 years after exposure, 20,000 to 40,000 person-
years ofrisk have been evaluated. Thirty-four (13%) of
these deaths were from cancer. This is not an unusual
proportion of deaths from malignant disease and the
distribution ofreported tumors does not appear partic-
ularly unusual (Table 1).
Conclusions
Although there is little solid evidence that 2,3,7,8-
TCDD produces substantial chronic disability or pre-
mature death in man, a significant body ofexperimental
evidence for its carcinogenicity makes it likely that a
small number of human malignancies may be due to it
action. Careful long-term follow-up of Missouri and
Vietnam cohorts will be essential in determining the
relative riskofcancerinthose exposedtothesubstance.
Subcellular, cellular, and whole-animal experiments
suggest that TCDD exerts much of its activity by in-
ducing enzymes that protect the intact organism from
the assault of environmental contaminants. Adminis-
tration of2ppb ofTCDD dailyfor2 years to rats caused
liver and fat concentrations of24 and 8.1 ppb, increased
mortality, failure to gain weight, and damage to many
organ systems. Statistically significant increases in some
tumor frequencies but decreased frequencies for other
tumors at this dose of TCDD emphasize its complex
action on cell function.
Since tumors in animals are associated with other
clinical evidence of TCDD exposure and most exposed
workers who experience illnesses after exposure do not
develop malignant disease, the diagnosis of dioxin-as-
sociated illness should require an exposure history and
some other manifestations closely associated with TCDD
exposure. Signs and symptoms useful in establishing
the diagnosis ofdioxin-associated illness in a person are
any two or more ofthe following provided there is evi-
dence of exposure to 500 to 1000 ppb 2,3,7,8-TCDD for
more than 1 month in the preceding 5 years.
* Chloracne: severe acneform lesions temporally re-
lated to period ofmaximum exposure.
* Abnormal urinary excretion of uroporphyrin with
hirsutism
* Liver function abnormalities: specifically an ele-
vated SGPT, SGOT or GGT unexplained by other
causes
* Neuropathy proven by nerve conduction studies in
the lower extremities without other causes such as
alcoholism, diabetes, or disc disease
* Hypercholesterolemia or hypertriglyceridemia as-
sociated with weight loss or at least the absence of
obesity. The relationship is strengthened ifhyper-
lipidemiaistemporally relatedto exposure and was
not present prior to exposure
* Documentable evidence ofprofound weakness and
depression. Weakness may be documented by ex-
ercise tolerance testing or ergometry. Depression
should be documented by use ofpsychometric test-
ing and reliable psychiatric consultation
Soft tissue sarcoma in an exposed individual should
raise suspicion of a relationship to 2,3,7,8-exposure if
at leastone othersignorsymptomispresent. Chloracne
appears to be both sensitive and specific; abnormal por-
phyrin excretion with hirsutism is quite specific but not
particularly sensitive; hypercholesterolemia is quite
nonspecific. These abnormalities can be used to con-
struct a set of criteria for the diagnosis of dioxin-asso-
ciatedillness (Webb, Ayres, Evans, andMikes, inpress).
Unlike many chemicals which have important and re-
deemingsocialvalue, 2,3,7,8-TCDDisanunwanted con-
taminant thatcould be eliminated withlittle measurable
consequence. High national priority must be given to
the disposal ofTCDD from existing contaminated areas
andtoidentificationandcompensationofthosewhohave
suffered serious health problems.
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